SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Carolina celebrates the Class of 2024 at winter commencement
After years of hard work — whether it be class readings, group projects, student group activities, papers, late nights studying or exams — graduating UNC...
Sun Dec 22, 2024

A playlist of Chapel Hill-themed holiday songs
Joni Mitchell went Christmas caroling in the Morgan Creek neighborhood in December 1970 with her then boyfriend, James Taylor. Six months later, Mitchell’s album Blue...
Fri Dec 20, 2024

Video: New UNC Football coach Bill Belichick brings in big business for stores in Chapel Hill
Many Franklin Street businesses in Chapel Hill are reaping the benefits, following the news that Bill Belichick, one of the greatest NFL coaches of all...
Tue Dec 17, 2024

Carolina Insider Podcast: UNC vs. Florida Basketball preview, Hubert Davis joins, Be Loud! Sophie
UNC Basketball cruised past La Salle, but faces a much stiffer test Tuesday against Florida (2:20). Hubert Davis checks in (28:07). Niklaus and Lucy Steiner...
Tue Dec 17, 2024